AAAAAA
Results:
1-12
|
Results: 12
Authors:
GRANCHA S
ESTELLES A
FALCO C
CHIRIVELLA N
ESPANA F
AZNAR J
Citation: S. Grancha et al., DETAILED LOCALIZATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR MESSENGER-RNA EXPRESSION AND ANTIGEN IN ATHEROSCLEROTIC PLAQUE ON HUMAN CORONARY-ARTERY, FIBRINOLYSIS & PROTEOLYSIS, 12(1), 1998, pp. 53-60
Authors:
ESTELLES A
GILABERT J
GRANCHA S
YAMAMOTO K
THINNES T
ESPANA F
AZNAR J
LOSKUTOFF DJ
Citation: A. Estelles et al., ABNORMAL EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE FACTOR IN SEVERE PREECLAMPSIA, Thrombosis and haemostasis, 79(3), 1998, pp. 500-508
Authors:
AZNAR J
VILLA P
ESPANA F
ESTELLES A
GRANCHA S
FALCO C
Citation: J. Aznar et al., PHENOTYPIC RESISTANCE TO ACTIVATED PROTEIN-C IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES, Thrombosis and haemostasis, 1997, pp. 1307-1307
Authors:
GRANCHA S
ESTELLES A
GILABERT J
CHIRIVELLA M
ESPANA F
AZNAR J
Citation: S. Grancha et al., ALTERED EXPRESSION OF PAI-2 MESSENGER-RNA IN PLACENTAS FROM PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION (IUGR), Thrombosis and haemostasis, 1997, pp. 1454-1454
Authors:
AZNAR J
VILLA P
ESPANA F
ESTELLES A
GRANCHA S
FALCO C
Citation: J. Aznar et al., ACTIVATED PROTEIN-C RESISTANCE PHENOTYPE IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES, The Journal of laboratory and clinical medicine, 130(2), 1997, pp. 202-208
Authors:
GRANCHA S
ESTELLES A
GILABERT J
CHIRIVELLA M
ESPANA F
AZNAR J
Citation: S. Grancha et al., DECREASED EXPRESSION OF PAI-2 MESSENGER-RNA AND PROTEIN IN PREGNANCIES COMPLICATED WITH INTRAUTERINE PETAL GROWTH-RETARDATION, Thrombosis and haemostasis, 76(5), 1996, pp. 761-767
Authors:
ESTELLES A
GRANCHA S
GILABERT J
THINNES T
CHIRIVELLA M
ESPANA F
AZNAR J
LOSKUTOFF DJ
Citation: A. Estelles et al., ABNORMAL EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITORS IN PATIENTS WITH GESTATIONAL TROPHOBLASTIC DISEASE, The American journal of pathology, 149(4), 1996, pp. 1229-1239
Authors:
ESTELLES A
GILABERT J
CANO A
ESPANA F
BARRACHINA R
GRANCHA S
AZNAR J
TORTAJADA M
Citation: A. Estelles et al., THE EFFECT OF HORMONE-REPLACEMENT THERAPY ON THE FIBRINOLYTIC SYSTEM,COAGULATION INHIBITORS AND LIPOPROTEIN(A) IN POSTMENOPAUSAL STATUS, Thrombosis and haemostasis, 73(6), 1995, pp. 1135-1135
Authors:
GILABERT J
ESTELLES A
GRANCHA S
ESPANA F
AZNAR J
Citation: J. Gilabert et al., FIBRINOLYTIC SYSTEM AND REPRODUCTIVE PROCESS WITH SPECIAL REFERENCE TO FIBRINOLYTIC FAILURE IN PREECLAMPSIA, Human reproduction, 10, 1995, pp. 121-131
Authors:
GILABERT J
ESTELLES A
CANO A
ESPANA F
BARRACHINA R
GRANCHA S
AZNAR J
TORTAJADA M
Citation: J. Gilabert et al., THE EFFECT OF ESTROGEN REPLACEMENT THERAPY WITH OR WITHOUT PROGESTOGEN ON THE FIBRINOLYTIC SYSTEM AND COAGULATION INHIBITORS IN POSTMENOPAUSAL STATUS, American journal of obstetrics and gynecology, 173(6), 1995, pp. 1849-1854
Authors:
GILABERT J
ESTELLES A
AYUSO MJ
ESPANA F
CHIRIVELLA M
GRANCHA S
MICO JM
AZNAR J
Citation: J. Gilabert et al., EVALUATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMA AND AMNIOTIC-FLUID IN PREGNANCIES COMPLICATED WITH INTRAUTERINE FETAL GROWTH-RETARDATION, Gynecologic and obstetric investigation, 38(3), 1994, pp. 157-162
Authors:
ESTELLES A
GILABERT J
KEETON M
EGUCHI Y
AZNAR J
GRANCHA S
ESPANA F
LOSKUTOFF DJ
SCHLEEF RR
Citation: A. Estelles et al., ALTERED EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PLACENTAS FROM PREGNANT-WOMEN WITH PREECLAMPSIA AND OR INTRAUTERINE PETAL GROWTH-RETARDATION/, Blood, 84(1), 1994, pp. 143-150
Risultati:
1-12
|